Matthew Shair

Matthew Shair

Corporate Officer/Principal at
Harvard University

Net worth: 174 M $ as of 2026-05-30

57 year
Consumer Services
Health Technology

Profile

Matthew D.
Shair
was the founder of Infinity Pharmaceuticals, Inc., founded in 1995, and Nuvalent, Inc., founded in 2017, where he held the title of Director from 2017 to 2025.
Dr. Shair is also the founder of Chemiderm, Inc.,Makoto Life Sciences, Inc...
Dr. Shair currently holds the position of Professor at Harvard University since 1997.
Additionally, Dr. Shair is an Associate at Harvard Stem Cell Institute and an Associate at The Broad Institute, Inc. Dr. Shair completed undergraduate education at Rochester Christian University, graduate education at Yale University, and earned a doctorate from The Trustees of Columbia University in The City of New York.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-11-23 1,578,866 ( 2.35% ) 174 M $ 2026-05-30

Matthew Shair active positions

CompaniesPositionStart
Corporate Officer/Principal 1997-05-31
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Matthew Shair

CompaniesPositionEnd
NUVALENT, INC. Founder 2025-12-08
Chemiderm, Inc.
Founder -
Makoto Life Sciences, Inc.
Founder -
INFINITY PHARMACEUTICALS, INC. Founder -
See the detail of Matthew Shair's experience

Training of Matthew Shair

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

98

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Chemiderm, Inc.

Health Technology

Makoto Life Sciences, Inc.

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!